WP
TVTX icon

Woodline Partners’s Travere Therapeutics TVTX Stock Holding History

Woodline Partners’s Portfolio TVTX Stock Details TVTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.99M Buy
302,666
+138,402
+84% +$4.14M 0.03% 540
2025
Q4 		$6.28M Buy
164,264
+74,936
+84% +$2.44M 0.02% 571
2025
Q3 		$2.13M Sell
89,328
-411,667
-82% -$7.74M 0.01% 726
2025
Q2 		$7.41M Sell
500,995
-728,783
-59% -$12.1M 0.04% 487
2025
Q1 		$22M Sell
1,229,778
-884,278
-42% -$17.9M 0.14% 213
2024
Q4 		$36.8M Sell
2,114,056
-2,226,284
-51% -$39.4M 0.25% 124
2024
Q3 		$60.7M Buy
4,340,340
+3,063,462
+240% +$31.9M 0.51% 45
2024
Q2 		$10.5M Buy
+1,276,878
New +$8.6M 0.1% 242
2024
Q1 		– Sell
-636,621
Closed -$5.72M – 637
2023
Q4 		$5.72M Sell
636,621
-1,513,944
-70% -$11M 0.06% 303
2023
Q3 		$19.2M Buy
2,150,565
+1,110,269
+107% +$15.7M 0.23% 137
2023
Q2 		$16M Sell
1,040,296
-399,403
-28% -$7.27M 0.19% 159
2023
Q1 		$32.4M Buy
1,439,699
+1,342,791
+1,386% +$28.5M 0.44% 65
2022
Q4 		$2.04M Sell
96,908
-171,267
-64% -$3.63M 0.03% 472
2022
Q3 		$6.61M Buy
+268,175
New +$6.93M 0.09% 250
2021
Q4 		– Sell
-145,918
Closed -$3.54M – 791
2021
Q3 		$3.54M Buy
+145,918
New +$2.68M 0.06% 308
2020
Q1 		– Sell
-281,423
Closed -$4M – 172
2019
Q4 		$4M Buy
+281,423
New +$3.59M 0.16% 96

Other funds holding TVTX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Woodline Partners's TVTX Position: Q1 2026 in Review

Woodline Partners increased its Travere Therapeutics (TVTX) stake by 84% in Q1 2026, buying an estimated $4.14M and bringing the position to 302,666 shares worth $8.99M. The position accounts for 0.03% of the portfolio, ranked #540.

Woodline Partners first reported a position in TVTX in Q4 2019 and has held it in 16 quarters since. The position peaked at $60.7M in Q3 2024. 260 funds tracked by Wall St. Rank hold TVTX as of Q1 2026.

  • Woodline Partners held 302,666 shares of Travere Therapeutics worth $8.99M as of Q1 2026.
  • Woodline Partners bought 138,402 Travere Therapeutics shares in Q1 2026, an estimated $4.14M.
  • Travere Therapeutics made up 0.03% of Woodline Partners's portfolio in Q1 2026, its #540 holding.
  • Woodline Partners first reported a position in Travere Therapeutics in Q4 2019 and has held it in 16 quarters since.
  • Woodline Partners's Travere Therapeutics position peaked at $60.7M in Q3 2024.
  • 260 funds tracked by Wall St. Rank held Travere Therapeutics as of Q1 2026.

Based on Woodline Partners's 13F filing for Q1 2026, filed 15 May 2026.